Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer

Epigenetic silencing mediated by CpG methylation is a common feature of many cancers. Characterizing aberrant DNA methylation changes associated with tumor progression may identify potential prognostic markers for prostate cancer (PCa). We treated two PCa cell lines, 22Rv1 and DU-145 with the demeth...

Descripción completa

Detalles Bibliográficos
Autores principales: White-Al Habeeb, Nicole M. A., Ho, Linh T., Olkhov-Mitsel, Ekaterina, Kron, Ken, Pethe, Vaijayanti, Lehman, Melanie, Jovanovic, Lidija, Fleshner, Neil, van der Kwast, Theodorus, Nelson, Colleen C., Bapat, Bharati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202166/
https://www.ncbi.nlm.nih.gov/pubmed/25277202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202166/
https://www.ncbi.nlm.nih.gov/pubmed/25277202

Ejemplares similares